Trial intelligence / Profile preview

Phase II trial of HBW-004285 for postoperative pain after hallux valgus correction surgery

CTR20252517Phase 2Active

Sponsor
Hyperway Pharmaceutical
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of HBW-004285 in acute postoperative pain, sponsored by Hyperway Pharmaceutical. Started Jul 2025; status: active.

02

Drugs

HBW-004285
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on CTR20252517.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20252517.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call